Search filters

List of works by Eileen M Boyle

A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma

scientific article

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

scientific article

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

scientific article published on 19 August 2019

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

scientific article

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma

scientific article published on 02 February 2015

BRAF and DIS3 Mutations Associate with Adverse Outcome in a Long-term Follow-up of Patients with Multiple Myeloma

scientific article published on 27 January 2020

Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors

scientific article

Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations

scientific article

Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial

scientific article published on 19 June 2019

Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population

scientific article published on 19 November 2019

Early coagulopathy in trauma patients: an on-scene and hospital admission study.

scientific article published on 26 November 2010

Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.

scientific article published on 30 December 2011

Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.

scientific article published on 7 March 2017

Evaluation of the Relevance of Surgery in Patients with Multiple Myeloma Harboring Symptomatic Spinal Involvement: A Retrospective Case Series

scientific article published on 09 March 2018

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

scientific article published on 17 November 2017

Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

scientific article published on 01 January 2022

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia

scientific article published on 21 October 2015

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.

scientific article published on 07 March 2013

Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteria

scientific article

Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series

scientific article published on 18 November 2016

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

scientific article published on 12 August 2014

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

scientific article published on 11 May 2016

Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis.

scientific article published on December 2012

MELISSE, a large multicentric observational study to determine risk factors of venous thromboembolism in patients with multiple myeloma treated with immunomodulatory drugs

scientific article published in August 2013

MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome

scientific article

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study

scientific article published on 06 January 2020

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma.

scientific article published on 17 August 2015

Novel M-component based biomarkers in Waldenström's macroglobulinemia

scientific article published on 01 February 2011

Ongoing development of monoclonal antibodies and antibody drug-conjugates in lymphoma

scientific article published on 01 October 2011

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma

scientific article published on 25 February 2015

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.

scientific article published on 06 June 2017

Prognostic value of PINI index in patients with multiple myeloma.

scientific article published on 4 January 2012

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

scientific article published on 4 December 2017

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

scientific article published on 11 October 2016

The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.

scientific article published on 27 May 2016

The genomic landscape of plasma cells in systemic light chain amyloidosis

scientific article published on 16 November 2018

The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma

scientific article published on 26 May 2017

Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients

scientific article

Treatment of Newly Diagnosed Elderly Multiple Myeloma.

scientific article published on January 2016

Understanding the multiple biological aspects leading to myeloma

scientific article published on April 2014